Homebased Monitoring Cardiac Rehabilitation Program

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud148 enrolled

Overview

The current state of mobile communication and technology is a tool to support home programs for chronic disease management, useful to facilitate access to these types of programs, because the investigators could obtain telematics information about the parameters, reducing cardiovascular risk factors and cardiovascular morbidity and mortality. Once the patient qualifies for inclusion in the study and has signed informed consent it is included in a list where randomized 7 patients in the experimental group (home-based cardiac rehabilitation Nuubo monitoring vest) and 7 patients are assigned to traditional cardiac rehabilitation group.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

148

Conditions

Homebased Cardiac Rehabilitation Program After Ischemic Heart Disease

Interventions

Homebased cardiac rehabilitation programDEVICE

homebased cardiac rehabilitation program with monitoring vest Nuubo

Traditional cardiac rehabilitation programOTHER

multidisciplinary intervention in cardiac rehabilitation gym

Eligibility

Sex: ALLMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: All of them: * Age ≤ 80 years. * Stable Ischemic heart disease, revascularized by angioplasty or underwent surgery by coronary bypass \<= one year from the acute episode. * Good cognitive level. * Ability to perform aerobic exercise tape or cycle ergometer. * Understand the use of a mobile Smartphone or Tablet. * Signature of informed consent. And at least one of the following: * Ventricular dysfunction by Ejection Fraction (FE) 40 - 50%. * Functional capacity 5-7 metabolic equivalents (METS). * Raising the blood pressure with the effort. Exclusion Criteria: * Presence of malignant arrhythmias such as ventricular fibrillation outside the acute phase of Acute myocardial infarction (AMI) (\> 24 h after AMI), ventricular tachycardia, Atrioventricular block of 2nd degree and 3rd degree, Atrial fibrilation (FA) in patients with Wolf Parkinson White, fibrillation or paroxysmal atrial flutter with response ventricular quickly and hemodynamic deterioration, premature ventricular contractions increases during exertion, paroxysmal supraventricular tachycardia uncontrolled. * Previous infarcts. * Hypotensive response to exercise. * Myocardial Ischemia valued at exercise test. * Unstable Angina. * Nonrevascularizable disease. * Poorly controlled hypertension baseline. * Killip III and IV Killip. * No collaborator. * Valvular heart disease associated. * Pacemaker or Implantable Cardioverter Defibrillator. * Pathology of musculoskeletal, neurological or breathing that impair the ability of prolonged ambulation.

Locations (3)

Hospital Mediterráneo

Almería, Almería, Spain

RECRUITING

Hospital Reina Sofía

Córdoba, Córdoba, Spain

RECRUITING

Hospital Universitario Virgen de la Victoria

Málaga, Malaga, Spain

RECRUITING

Outcomes

Primary Outcomes

Effectiveness measured by exercise testing and control of cardiovascular risk factors

functional capacity obtained by exercise testing and control of cardiovascular risk factors.

Time frame: During 12 months

Secondary Outcomes

Results of homebased cardiac rehabilitation monitoring a traditional cardiac rehabilitation program

comparing the results of functional capacity measured by exercise testing and control of cardiovascular risk factors between the two groups

Time frame: During 12 months

Adherence to these programs

see adherence to these program at 3, 6 months and a year depending on the habit of exercise and control of cardiovascular risk factors.

Time frame: 3, 6 and 12 months

Safety to these program

See the safety of home cardiac rehabilitation program of mixed surveillance compared to traditional cardiac rehabilitation program to checking the existence of adverse cardiac events.

Time frame: During 12 months

Central Contacts

Raquel Bravo, MD

CONTACT

34951291977 rbravoescobar@yahoo.es

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.